Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study
Top Cited Papers
Open Access
- 1 October 2019
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 394 (10205) , 1254-1263
Abstract
No abstract availableKeywords
Funding Information
- European Commission (FP7–242209-BIOSTAT-CHF)
This publication has 24 references indexed in Scilit:
- Asian Sudden Cardiac Death in Heart Failure (ASIAN-HF) RegistryEuropean Journal of Heart Failure, 2013
- Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trialThe Lancet, 2009
- Sex Differences in Pharmacokinetics and PharmacodynamicsClinical Pharmacokinetics, 2009
- Therapeutic implications of the gender-specific aspects of cardiovascular diseaseNature Reviews Drug Discovery, 2006
- Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseasesEuropean Heart Journal, 2005
- Patterns of treatment effects in subsets of patients in clinical trialsBiostatistics, 2004
- PM Frequencies of Major CYPs in Asians and CaucasiansDrug Metabolism Reviews, 2003
- Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart FailureNew England Journal of Medicine, 2002
- Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart FailureCirculation, 1999
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997